Terms: = Liver cancer AND FAS, FAS1, 355, ENSG00000026103, FASTM, APO-1, P25445, CD95, ALPS1A, TNFRSF6, APT1 AND Treatment
315 results:
1. Integrating Navigation-Assisted Ablation in the Locoregional treatment of Hepatocellular Carcinoma.
Iwai Y; Agala CB; Gerber DA
JAMA Netw Open; 2024 Feb; 7(2):e240694. PubMed ID: 38421644
[TBL] [Abstract] [Full Text] [Related]
2. Effect of Hospital cancer Designation on use of Multimodal Therapy and Survival of Metastatic Colorectal cancer: A State-Wide Analysis.
Meier J; Murimwa G; Nehrubabu M; DiMartino L; Singal AG; Karagkounis G; Yopp A; Zeh HJ; Polanco PM
Ann Surg Oncol; 2024 Apr; 31(4):2591-2597. PubMed ID: 38245645
[TBL] [Abstract] [Full Text] [Related]
3. Evaluation of the inhibitory effect of azoles on pharmacokinetics of lenvatinib in rats both in vivo and in vitro by UPLC-MS/MS.
Xia M; Song X; Lu Z; Wang Y; Zhou Q; Geng P; Wang S; Zhou Y; Wu Q; Han A
Thorac Cancer; 2023 Nov; 14(33):3331-3341. PubMed ID: 37771131
[TBL] [Abstract] [Full Text] [Related]
4. Inverse probability of treatment weighting analysis of laparoscopic versus open Sg4b-5 bi-segmentectomy in patients with gallbladder cancer.
Fontana AP; Russolillo N; Di Menno Stavron J; Langella S; Tesoriere RL; Ricotti A; Ferrero A
Updates Surg; 2023 Sep; 75(6):1471-1480. PubMed ID: 37495871
[TBL] [Abstract] [Full Text] [Related]
5. Deacetylation via SIRT2 prevents keratin-mutation-associated injury and keratin aggregation.
Sun J; Li P; Gui H; Rittié L; Lombard DB; Rietscher K; Magin TM; Xie Q; Liu L; Omary MB
JCI Insight; 2023 Jul; 8(14):. PubMed ID: 37485877
[TBL] [Abstract] [Full Text] [Related]
6. Polystyrene microplastics trigger adiposity in mice by remodeling gut microbiota and boosting fatty acid synthesis.
Huang H; Wei F; Qiu S; Xing B; Hou J
Sci Total Environ; 2023 Sep; 890():164297. PubMed ID: 37211133
[TBL] [Abstract] [Full Text] [Related]
7. Antihepatoma peptide, scolopentide, derived from the centipede scolopendra subspinipes mutilans.
Hu YX; Liu Z; Zhang Z; Deng Z; Huang Z; Feng T; Zhou QH; Mei S; Yi C; Zhou Q; Zeng PH; Pei G; Tian S; Tian XF
World J Gastroenterol; 2023 Mar; 29(12):1875-1898. PubMed ID: 37032730
[TBL] [Abstract] [Full Text] [Related]
8. Risk Factors for Hyperuricemia or Gout in Men and Women: The Circulatory Risk in Communities Study (CIRCS).
Teramura S; Yamagishi K; Umesawa M; Hayama-Terada M; Muraki I; Maruyama K; Tanaka M; Kishida R; Kihara T; Takada M; Ohira T; Imano H; Shimizu Y; Sankai T; Okada T; Kitamura A; Kiyama M; Iso H
J Atheroscler Thromb; 2023 Oct; 30(10):1483-1491. PubMed ID: 36878531
[TBL] [Abstract] [Full Text] [Related]
9. Bigelovin inhibits hepatocellular carcinoma cell growth and metastasis by regulating the MAPT-mediated fas/fasL pathway.
Wang B; Nie CH; Xu J; Wan DL; Xu X; He JJ
Neoplasma; 2023 Apr; 70(2):208-215. PubMed ID: 36812233
[TBL] [Abstract] [Full Text] [Related]
10. Afatinib in Untreated Stage IIIB/IV Lung Adenocarcinoma with Major Uncommon Epidermal Growth Factor Receptor (EGFR) Mutations (G719X/L861Q/S768I): A Multicenter Observational Study in Taiwan.
Hsu PC; Lee SH; Chiu LC; Lee CS; Wu CE; Kuo SC; Ju JS; Huang AC; Li SH; Ko HW; Yang CT; Wang CC
Target Oncol; 2023 Mar; 18(2):195-207. PubMed ID: 36805452
[TBL] [Abstract] [Full Text] [Related]
11. Effect of valproic acid on extrinsic and intrinsic apoptotic pathways, cell viability and apoptosis in hepatocellular carcinoma PLC/PRF5 cell line.
Lu Y; Liu Y; Zhang K; Jiang L
Cell Mol Biol (Noisy-le-grand); 2022 Aug; 68(8):139-144. PubMed ID: 36800819
[TBL] [Abstract] [Full Text] [Related]
12. Life expectancy of patients with hepatocellular carcinoma according to the upfront treatment: A nationwide analysis.
Cassinotto C; Nogue E; Durand Q; Panaro F; Assenat E; Dohan A; Malafaye N; Guiu B; Molinari N
Diagn Interv Imaging; 2023 Apr; 104(4):192-199. PubMed ID: 36682959
[TBL] [Abstract] [Full Text] [Related]
13. Increased Spleen Volume in Hepatocellular Carcinoma Patients Treated with Atezolizumab plus Bevacizumab in Comparison to Lenvatinib: A Retrospective Analysis.
Hatanaka T; Naganuma A; Furusawa A; Tamura Y; Saito N; Suzuki Y; Hoshino T; Yata Y; Uraoka T; Kakizaki S
Oncology; 2023; 101(3):193-202. PubMed ID: 36649691
[TBL] [Abstract] [Full Text] [Related]
14. Aidi injection enhances the anti-tumor impact of doxorubicin in H22 tumor-containing mice.
Lu Y; Zhang S; Zhu X; Wang K; He Y; Liu C; Sun J; Pan J; Zheng L; Liu W; Li Y; Huang Y; Liu T
J Ethnopharmacol; 2023 Mar; 303():115968. PubMed ID: 36473617
[TBL] [Abstract] [Full Text] [Related]
15. Discovery and optimization of 2-(trifluoromethyl)benzimidazole derivatives as novel ferroptosis inducers in vitro and in vivo.
Fang Y; Tan Q; Zhou H; Xu J; Gu Q
Eur J Med Chem; 2023 Jan; 245(Pt 1):114905. PubMed ID: 36410168
[TBL] [Abstract] [Full Text] [Related]
16. Determining the temporal, dose, and composition effects of nutritional substrates in an in vitro model of intrahepatocellular triglyceride accumulation.
Nagarajan SR; Cross E; Johnson E; Sanna F; Daniels LJ; Ray DW; Hodson L
Physiol Rep; 2022 Oct; 10(20):e15463. PubMed ID: 36301719
[TBL] [Abstract] [Full Text] [Related]
17. CD36 accelerates the progression of hepatocellular carcinoma by promoting fas absorption.
Tao L; Ding X; Yan L; Xu G; Zhang P; Ji A; Zhang L
Med Oncol; 2022 Sep; 39(12):202. PubMed ID: 36175596
[TBL] [Abstract] [Full Text] [Related]
18. Factors affecting prognosis in hepatocellular carcinoma patients post-transarterial chemoembolization.
Prateepchaiboon T; Chang A; Pungpipattrakul N; Akarapatima K; Rattanasupar A; Songjamrat A; Pakdeejit S; Piratvisuth T
Indian J Gastroenterol; 2022 Aug; 41(4):352-361. PubMed ID: 36029371
[TBL] [Abstract] [Full Text] [Related]
19. [
Wang M; Zhou ZG; Du KP; Li S; Li YD; Gao F; Gao JB
Zhonghua Yi Xue Za Zhi; 2022 Aug; 102(31):2458-2464. PubMed ID: 36000376
[No Abstract] [Full Text] [Related]
20. The treatment of Human Colon Xenografts Tumor in Mice with Platinum Nanosphere-5-Fluorouracil-Bovine Albumin.
Li H; Sun Y; Gao LL; Tang YF; Zhao Z
J Biomed Nanotechnol; 2022 Mar; 18(3):778-787. PubMed ID: 35715920
[TBL] [Abstract] [Full Text] [Related]
[Next]
